Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 6709 to 6712 of 6712 entries
Sorted by: Best Match Show Resources per page
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.

Journal of the National Cancer Institute

Yin J, Salem ME, Dixon JG, Jin Z, Cohen R, DeGramont A, Van Cutsem E, Taieb J, Alberts SR, Wolmark N, Schmoll HJ, Saltz LB, George TJ, Goldberg RRM, Kerr R, Lonardi S, Yoshino T, Yothers G, Grothey A, Andre T, Shi Q.
PMID: 34505880
J Natl Cancer Inst. 2022 Jan 11;114(1):60-67. doi: 10.1093/jnci/djab187.

BACKGROUND: Disease-free survival (DFS) with a 3-year median follow-up (3-year DFS) was validated as a surrogate for overall survival (OS) with a 5-year median follow-up (5-year OS) in adjuvant chemotherapy colon cancer (CC) trials. Recent data show further improvements...

Cite
Yin J, Salem ME, Dixon JG, et al. Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials. J Natl Cancer Inst. 2022;114(1):60-67doi: 10.1093/jnci/djab187.
Yin, J., Salem, M. E., Dixon, J. G., Jin, Z., Cohen, R., DeGramont, A., Van Cutsem, E., Taieb, J., Alberts, S. R., Wolmark, N., Schmoll, H. J., Saltz, L. B., George, T. J., Goldberg, R. R. M., Kerr, R., Lonardi, S., Yoshino, T., Yothers, G., Grothey, A., Andre, T., & Shi, Q. (2022). Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials. Journal of the National Cancer Institute, 114(1), 60-67. https://doi.org/10.1093/jnci/djab187
Yin, Jun, et al. "Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials." Journal of the National Cancer Institute vol. 114,1 (2022): 60-67. doi: https://doi.org/10.1093/jnci/djab187
Yin J, Salem ME, Dixon JG, Jin Z, Cohen R, DeGramont A, Van Cutsem E, Taieb J, Alberts SR, Wolmark N, Schmoll HJ, Saltz LB, George TJ, Goldberg RRM, Kerr R, Lonardi S, Yoshino T, Yothers G, Grothey A, Andre T, Shi Q. Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials. J Natl Cancer Inst. 2022 Jan 11;114(1):60-67. doi: 10.1093/jnci/djab187. PMID: 34505880; PMCID: PMC8755492.
Copy Download .nbib Format: NLM
Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing.

International journal of biological macromolecules

Abdel Khalek MA, Abdel Gaber SA, El-Domany RA, El-Kemary MA.
PMID: 34774864
Int J Biol Macromol. 2021 Dec 15;193:1752-1766. doi: 10.1016/j.ijbiomac.2021.11.012. Epub 2021 Nov 12.

This study aimed to synthesize cellulose acetate (CA)-based electrospun nanofibers as drug delivery dressings for chronic wound healing. For the first time, CA was blended with polyethylene oxide (PEO) using acetone and formic acid. Methylene blue (MB) was incorporated...

Cite
Abdel Khalek MA, Abdel Gaber SA, El-Domany RA, et al. Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing. Int J Biol Macromol. 2021;193:1752-1766doi: 10.1016/j.ijbiomac.2021.11.012.
Abdel Khalek, M. A., Abdel Gaber, S. A., El-Domany, R. A., & El-Kemary, M. A. (2021). Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing. International journal of biological macromolecules, 1931752-1766. https://doi.org/10.1016/j.ijbiomac.2021.11.012
Abdel Khalek, Mohamed A, et al. "Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing." International journal of biological macromolecules vol. 193 (2021): 1752-1766. doi: https://doi.org/10.1016/j.ijbiomac.2021.11.012
Abdel Khalek MA, Abdel Gaber SA, El-Domany RA, El-Kemary MA. Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing. Int J Biol Macromol. 2021 Dec 15;193:1752-1766. doi: 10.1016/j.ijbiomac.2021.11.012. Epub 2021 Nov 12. PMID: 34774864.
Copy Download .nbib Format: NLM
Staff testing for COVID-19 via an online pre-registration form.

Southern African journal of infectious diseases

Moolla MS, Parker A, Parker MA, Sithole S, Amien L, Chiecktey R, Bawa T, Mowlana A.
PMID: 34485499
S Afr J Infect Dis. 2021 Jan 22;36(1):232. doi: 10.4102/sajid.v36i1.232. eCollection 2021.

BACKGROUND: Healthcare workers are at increased risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potentially causing institutional outbreaks. Staff testing is critical in identifying and isolating infected individuals, whilst also reducing unnecessary workforce depletion. Tygerberg Hospital...

Cite
Moolla MS, Parker A, Parker MA, et al. Staff testing for COVID-19 via an online pre-registration form. S Afr J Infect Dis. 2021;36(1):232doi: 10.4102/sajid.v36i1.232.
Moolla, M. S., Parker, A., Parker, M. A., Sithole, S., Amien, L., Chiecktey, R., Bawa, T., & Mowlana, A. (2021). Staff testing for COVID-19 via an online pre-registration form. Southern African journal of infectious diseases, 36(1), 232. https://doi.org/10.4102/sajid.v36i1.232
Moolla, Muhammad S, et al. "Staff testing for COVID-19 via an online pre-registration form." Southern African journal of infectious diseases vol. 36,1 (2021): 232. doi: https://doi.org/10.4102/sajid.v36i1.232
Moolla MS, Parker A, Parker MA, Sithole S, Amien L, Chiecktey R, Bawa T, Mowlana A. Staff testing for COVID-19 via an online pre-registration form. S Afr J Infect Dis. 2021 Jan 22;36(1):232. doi: 10.4102/sajid.v36i1.232. eCollection 2021. PMID: 34485499; PMCID: PMC8378193.
Copy Download .nbib Format: NLM
Gender and science: Women Nobel laureates.

Charyton Christine, Elliott JohnO, Rahman MohammedA, Woodard JenessL, Dedios Samantha.
UIID-AD: 1572
2011;45:203-214. doi: 10.1002/j.2162-6057.2011.tb01427.x.

Women and their creativity are underrepresented in science. To date, few women have been awarded the Nobel Prize in science. Eleven female Nobel laureates in physics, chemistry and physiology/medicine between 1901 and 2006 were compared with 37 males who...

Cite
Charyton Christine, Elliott JohnO, Rahman MohammedA, et al. Gender and science: Women Nobel laureates. 2011;45:203-214doi: 10.1002/j.2162-6057.2011.tb01427.x.
Charyton, C. h. r. i. s. t. i. n. e., Elliott, J. o. h. n. O., Rahman, M. o. h. a. m. m. e. d. A., Woodard, J. e. n. e. s. s. L., & Dedios, S. a. m. a. n. t. h. a. (2011). Gender and science: Women Nobel laureates. 45203-214. https://doi.org/10.1002/j.2162-6057.2011.tb01427.x
Charyton, Christine, et al. "Gender and science: Women Nobel laureates." vol. 45 (2011): 203-214. doi: https://doi.org/10.1002/j.2162-6057.2011.tb01427.x
Charyton Christine, Elliott JohnO, Rahman MohammedA, Woodard JenessL, Dedios Samantha. Gender and science: Women Nobel laureates. 2011;45:203-214. doi: 10.1002/j.2162-6057.2011.tb01427.x. UIID-AD: 1572.
Copy Download .nbib Format: NLM
Showing 6709 to 6712 of 6712 entries